Biographical Info

Dr. Gallo is a Professor in the Rutgers-Robert Wood Johnson Medical School Department of Environmental and Occupational Medicine. He is a Diplomate of the American Board of Toxicology, and a Fellow of the Academy of Toxicological Sciences. Dr Gallo is an Adjunct Professor both in the School of Public Health and in the Department of Pharmacology and Toxicology in the Ernest Mario School of Pharmacy of Rutgers University. He is a founding member of the Environmental and Occupational Health Sciences Institute where he served as Director of Toxicology, and as Director of the NIEHS Center of Excellence. He was the founding Director of the Cancer Institute of New Jersey and Associate Dean for Research. Dr. Gallo is a renowned toxicologist with expertise in the area of dioxins and PCBs, experimental models in pharmacology and toxicology, cytoplasmic and cell surface receptors, hormone biology and mechanisms of hormonal and environmental carcinogenesis. His avocation is History of Toxicology. Dr. Gallo served on several NIH committees including the ALTOX-4 Study Section, Chair of the Board of Scientific Councilors of the National Toxicology Program, and member of the NIEHS Board of Councilors. He also served as Chair of the NCI Centers Review committee, as well as a member of several NAS/NRC Expert committees including Drinking Water and Health; Pesticides in the Diets of Infants and Children; Risk Assessment Methodology; and the National Research Council/Institute of Medicine Roundtable on Environmental Health Sciences, Research and Medicine. He served the US-EPA as a member of the Scientific Advisory Board, and the Dioxin Review Science Advisory Board. Dr. Gallo was Chair of the New Jersey Governor’s Pesticide Control Council, and the New Jersey Cancer Risk Commission. Dr. Gallo serves as a consultant to the academic, government and private sectors.

Research Areas

Dioxins; Experimental Models; Pharmacology and Toxicology; Ocular Toxicity; Cytoplasmic Receptors; Hormones; Mechanisms of Carcinogenesis; Cell Surface Receptors; and Chemical Carcinogenesis

Scholarly Activities

• 2011: Society of Toxicology Education Award
• 2001: Chair, Hormonal Carcinogenesis Gordon Research Conference
• 2000: Ambassador of Toxicology, Mid-Atlantic Society of Toxicology
• 1985: Chair, Mechanisms of Toxicity Gordon Research Conference
• 1985: UMDNJ Exceptional Merit Award
• 1979: Russell Sage College Outstanding Alumni
• 1971-1972: NIH Post Doctoral Fellow
• 1968-1971 NIH Pre-Doctoral Fellow

Recent Publications

1. Mescia, L, Mevoli, G, Lamacchia, CM, Gallo, M, Bia, P, Gaetano, D, Manna, A. Sinuous Antenna for UWB Radar Applications. Sensors (Basel). 2021;22 (1):. doi: 10.3390/s22010248. PubMed PMID:35009791 PubMed Central PMC8749522
2. Gallo, M, Forero, PA, Moreno, Á. Lung Cancer Screening: A Necessary Tool Not Accessible for the Whole Population. J Am Coll Radiol. 2022; :. doi: 10.1016/j.jacr.2021.11.005. PubMed PMID:35007508
3. Weber, AE, Gallo, MC, Bolia, IK, Cleary, EJ, Schroeder, TE, Rick Hatch, GF 3rd. Anabolic Androgenic Steroids in Orthopaedic Surgery: Current Concepts and Clinical Applications. J Am Acad Orthop Surg Glob Res Rev. 2022;6 (1):. doi: 10.5435/JAAOSGlobal-D-21-00156. PubMed PMID:34982051 PubMed Central PMC8735789
4. Ravera, F, Cirmena, G, Dameri, M, Gallo, M, Vellone, VG, Fregatti, P, Friedman, D, Calabrese, M, Ballestrero, A, Tagliafico, A et al.. Development of a hoRizontal data intEgration classifier for NOn-invasive early diAgnosis of breasT cancEr: the RENOVATE study protocol. BMJ Open. 2021;11 (12):e054256. doi: 10.1136/bmjopen-2021-054256. PubMed PMID:34972769 PubMed Central PMC8720992
5. Madzia, J, Kudrimoti, M, Turner, AN, Bessett, D, Gallo, MF. Ohio survey data assessing perceptions of abortion safety. Contraception. 2021; :. doi: 10.1016/j.contraception.2021.11.008. PubMed PMID:34971612
6. Natalicchio, A, Faggiano, A, Zatelli, MC, Argentiero, A, D’Oronzo, S, Marrano, N, Beretta, GD, Acquati, S, Adinolfi, V, Di Bartolo, P et al.. Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper. Crit Rev Oncol Hematol. 2022;169 :103572. doi: 10.1016/j.critrevonc.2021.103572. PubMed PMID:34954047
7. Turner, AN, Kline, D, Norris, A, Phillips, WG, Root, E, Wakefield, J, Li, ZR, Lemeshow, S, Spahnie, M, Luff, A et al.. Prevalence of current and past COVID-19 in Ohio adults. Ann Epidemiol. 2021; :. doi: 10.1016/j.annepidem.2021.11.009. PubMed PMID:34921991
8. Fregatti, P, Gipponi, M, Sparavigna, M, Diaz, R, Murelli, F, Depaoli, F, Baldelli, I, Gallo, M, Friedman, D. Standardized comparison of radioguided surgery with indocyanine green detection of the sentinel lymph node in early stage breast cancer patients: Personal experience and literature review. J Cancer Res Ther. ;17 (6):1530-1534. doi: 10.4103/jcrt.JCRT_772_19. PubMed PMID:34916390
9. Mannucci, E, Giaccari, A, Gallo, M, Bonifazi, A, Belén, ÁDP, Masini, ML, Trento, M, Monami, M. Self-management in patients with type 2 diabetes: Group-based versus individual education. A systematic review with meta-analysis of randomized trails. Nutr Metab Cardiovasc Dis. 2022;32 (2):330-336. doi: 10.1016/j.numecd.2021.10.005. PubMed PMID:34893413
10. Mannucci, E, Gallo, M, Pintaudi, B, Targher, G, Candido, R, Giaccari, A, Monami, M, SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes. All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2022;32 (2):511-514. doi: 10.1016/j.numecd.2021.10.010. PubMed PMID:34893404